scispace - formally typeset
S

Shigehiro Katayama

Researcher at Saitama Medical University

Publications -  251
Citations -  11344

Shigehiro Katayama is an academic researcher from Saitama Medical University. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 49, co-authored 251 publications receiving 10637 citations.

Papers
More filters
Journal ArticleDOI

A new method of bone tissue measurement based upon light scattering

TL;DR: The results show the possibility of obtaining information on internal bone structure and composition in vivo through assessment of the waveforms obtained by a time‐resolution system in the near infrared region.
Journal ArticleDOI

Lysophosphatidylcholine for efficient intestinal lipid absorption and lipoprotein secretion in caco-2 cells.

TL;DR: Findings confirm that the alteration of PC by PLA2 hydrolysis is intrinsically involved in the intestinal lipid absorption process and suggest that PC and its hydrolysates are coordinately associated with not only lipid absorption efficiency but also lipoprotein output and metabolism.
Journal ArticleDOI

Improvement of glucose tolerance by bezafibrate in non-obese patients with hyperlipidemia and impaired glucose tolerance.

TL;DR: Treatment to reduce the level of serum triglycerides, but not that of cholesterol, may have a beneficial effect for improving insulin resistance even in the non-obese subjects with IGT and decreasing the risk of coronary heart disease.
Journal ArticleDOI

Ezetimibe Promotes Brush Border Membrane-to-Lumen Cholesterol Efflux in the Small Intestine.

TL;DR: In this paper, the authors employed a trans-intestinal cholesterol efflux (TICE) assay, which directly detects circulation-to-intestinal lumen 3H-cholesterol transit in a cannulated jejunal segment, and found an increase of TICE by 45%.
Journal ArticleDOI

Serum substances that interfere with thyroid hormone assays in patients with chronic renal failure

TL;DR: Serum thyroid hormone concen_trations in patients with chronic renal failure are usually low, despite normal serum TSH levels, so the effect on thyroid hormone assays of serum dialysable organic acids that are elevated in uraemic patients is investigated.